Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone replacement therapy: current trends and future directions.

E Nieschlag1, H M Behre, P Bouchard

  • 1Institute of Reproductive Medicine of the University Domagkstr 11, D-48129 Munster, Germany. nieschl@uni-muenster.de

Human Reproduction Update
|August 7, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distribution and function of FSH receptor genetic variants in normal men.

Andrologia·2002
Same author

Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation.

Clinical endocrinology·2002
Same author

TestisBank: an internet-based gene sequence database of the testis.

International journal of andrology·2002
Same author

Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.

European journal of endocrinology·2002
Same author

Testosterone substitution of hypogonadal men prevents the age-dependent increases in body mass index, body fat and leptin seen in healthy ageing men: results of a cross-sectional study.

European journal of endocrinology·2002
Same author

The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males.

Clinical endocrinology·2002
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Testosterone replacement therapy effectively treats male hypogonadism symptoms. New delivery methods offer more options, but evidence-based guidelines are needed for optimal patient care and safety.

Area of Science:

  • Endocrinology
  • Men's Health
  • Pharmacology

Background:

  • Male hypogonadism involves low testosterone and symptoms like mood disturbance and sexual dysfunction.
  • Testosterone replacement therapy (TRT) can alleviate these symptoms by restoring normal levels.
  • Traditional TRT methods include injections and pellets, with newer options like patches and gels available.

Purpose of the Study:

  • To review the evolving landscape of testosterone replacement therapy for male hypogonadism.
  • To highlight the introduction of novel TRT formulations, such as buccal tablets.
  • To emphasize the need for updated, international, evidence-based guidelines for TRT diagnosis and monitoring.

Main Methods:

  • Review of existing literature on male hypogonadism and testosterone replacement therapy.

Related Experiment Videos

  • Analysis of current and emerging TRT modalities.
  • Discussion of the necessity for standardized diagnostic and monitoring protocols.

    • Main Results:

    • Several new TRT options, including transdermal gels and buccal tablets, have emerged.
    • These innovations necessitate a re-evaluation of treatment strategies and patient management.
    • Existing guidelines vary by country, indicating a need for global consensus.

    Conclusions:

    • The development of new TRT formulations provides additional choices for managing male hypogonadism.
    • Further research is required to establish comprehensive, evidence-based guidelines for TRT.
    • Internationally accepted guidelines are crucial for optimizing patient outcomes and ensuring safety across diverse populations.